Last reviewed · How we verify
NCT04555174: BIOFLOW-VIII
BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
trial testing Orsiro Mission DES in Coronary Artery Disease in 872 participants. Participants enrolled and being followed up; not accepting new ones.
18 January 2023
Quick facts
| Lead sponsor | Biotronik AG |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 872 |
| Start date | 25 September 2020 |
| Primary completion | 18 January 2023 |
| Estimated completion | 19 February 2027 |
| Sites | 41 locations across France |
Drugs / interventions tested
- Orsiro Mission DES
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Myocardial Ischemia — all drugs for Myocardial Ischemia →
Sponsor
Biotronik AG
Who can join
18 and older, any sex, with Coronary Artery Disease or Myocardial Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The BIOFLOW-VIII registry is a post-market clinical evaluation of the Orsiro Mission stent in subjects requiring coronary revascularization with Drug Eluting Stents (DES).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04555174
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Biotronik AG trials
Trials by the same sponsor.
- NCT06758921 — Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Per · recruiting
- NCT05831319 — Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular P · completed
- NCT04830228 — BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions · active not recruiting
- NCT04250909 — Retrospective Follow-up of BIOLUX P-I/-II · completed
- NCT04137510 — Bioflow-DAPT Study · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04555174 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biotronik AG
- Last refreshed: 21 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04555174.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing